- Home
- ZION vs TECH Comparison
ZION vs TECH Comparison
Compare ZION & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- TECH
- Stock Information
- Founded
- ZION 1873
- TECH 1976
- Country
- ZION United States
- TECH United States
- Employees
- ZION N/A
- TECH N/A
- Industry
- ZION Major Banks
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZION Finance
- TECH Health Care
- Exchange
- ZION Nasdaq
- TECH Nasdaq
- Market Cap
- ZION 7.4B
- TECH 8.0B
- IPO Year
- ZION N/A
- TECH 1989
- Fundamental
- Price
- ZION $44.28
- TECH $48.10
- Analyst Decision
- ZION Hold
- TECH Buy
- Analyst Count
- ZION 22
- TECH 9
- Target Price
- ZION $59.24
- TECH $81.25
- AVG Volume (30 Days)
- ZION 2.6M
- TECH 2.2M
- Earning Date
- ZION 04-21-2025
- TECH 05-07-2025
- Dividend Yield
- ZION 3.89%
- TECH 0.63%
- EPS Growth
- ZION 13.92
- TECH N/A
- EPS
- ZION 4.95
- TECH 0.98
- Revenue
- ZION $3,058,000,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- ZION $9.81
- TECH $8.19
- Revenue Next Year
- ZION $4.71
- TECH $8.85
- P/E Ratio
- ZION $8.95
- TECH $49.09
- Revenue Growth
- ZION 2.51
- TECH 4.46
- 52 Week Low
- ZION $39.05
- TECH $46.44
- 52 Week High
- ZION $63.22
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- ZION 42.94
- TECH 33.97
- Support Level
- ZION $42.77
- TECH $46.44
- Resistance Level
- ZION $46.41
- TECH $53.00
- Average True Range (ATR)
- ZION 2.77
- TECH 3.30
- MACD
- ZION 0.02
- TECH -0.27
- Stochastic Oscillator
- ZION 44.40
- TECH 13.00
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.